NT COVID-19 vaccine roll-out
The Australian Government is simplifying and accelerating the national approach to the COVID-19 vaccine roll-out.
The recalibrated vaccine roll-out strategy includes:
- Phases for people over 50 years will be collapsed
- From 3 May, all eligible adults over the age of 50 will be able to access the AstraZeneca COVID-19 vaccine from Respiratory clinics.
- From 17 May, eligible adults over the age of 50 will be able to access the AstraZeneca vaccine more broadly from participating GPs. Some participating GPs may commence earlier than this date.
- People who are under 50 year can access the AstraZeneca vaccine if they have informed consent
- Community pharmacists will be considered to provide the AstraZeneca vaccine in areas where there is no GP service
- People in Phase 1A and Phase 1B who are under 50 years can access the Pfizer vaccine from state and territory clinics.
- This includes health care and emergency services workers, aged care and disability workers and people under 50 with a specified medical condition.
- Access to the Pfizer vaccine will only be available to eligible adults under 50 years included in Phase1A and Phase 1B.
- The Pfizer vaccine can be used in remote communities, where the preferred model is to provide the COVID-19 vaccine to the whole community.
Following the announcement of the recalibrated vaccine roll-out strategy, NT Health is reviewing the NT implementation plan and booking system to increase community access to the COVID-19 vaccine and will provide more information about how you can access these services shortly.
As part of this we will be working closely with our Aboriginal health partners and the NTPHN to plan for the next stages of the vaccine roll-out, noting our young and vulnerable cohorts.